TABLE 4.
Unconstrained Schild slopes (95% confidence limits) calculated for pA2 analysis of rimonabant versus A-834,735D and CP55,940 did not statistically differ from unity for catalepsy, antinociception, and hypothermia
For subsequent pA2 analyses, slopes were constrained to –1.
| Unconstrained Slope | Catalepsy | Antinociception | Hypothermia |
|---|---|---|---|
| A-834,735D | −0.69 (–1.13 to –0.25) | −1.07 (–1.21 to –0.86) | −1.08 (–1.23 to –0.92) |
| CP55,940 | −1.11 (–3.0 to 0.85) | −0.99 (–2.165 to 0.18) | −1.03 (–2.75 to 0.68) |